Annual Operating Expenses
$647.40 M
-$86.46 M-11.78%
December 31, 2024
Summary
- As of March 6, 2025, ASND annual total operating expenses is $647.40 million, with the most recent change of -$86.46 million (-11.78%) on December 31, 2024.
- During the last 3 years, ASND annual operating expenses has risen by +$107.82 million (+19.98%).
- ASND annual operating expenses is now -11.78% below its all-time high of $733.86 million, reached on December 31, 2023.
Performance
ASND Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$170.03 M
+$12.34 M+7.83%
December 31, 2024
Summary
- As of March 6, 2025, ASND quarterly total operating expenses is $170.03 million, with the most recent change of +$12.34 million (+7.83%) on December 31, 2024.
- Over the past year, ASND quarterly operating expenses has increased by +$129.40 thousand (+0.08%).
- ASND quarterly operating expenses is now -11.05% below its all-time high of $191.16 million, reached on June 30, 2023.
Performance
ASND Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ASND Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -11.8% | +0.1% |
3 y3 years | +20.0% | +0.1% |
5 y5 years | +140.9% | +0.1% |
ASND Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -11.8% | +20.0% | -11.1% | +30.5% |
5 y | 5-year | -11.8% | +140.9% | -11.1% | +128.0% |
alltime | all time | -11.8% | +3479.0% | -11.1% | +3710.4% |
Ascendis Pharma A/S Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $647.40 M(-11.8%) | $170.03 M(+7.8%) |
Sep 2024 | - | $157.69 M(-7.2%) |
Jun 2024 | - | $169.90 M(+13.8%) |
Mar 2024 | - | $149.32 M(-10.5%) |
Dec 2023 | $733.86 M(+15.8%) | $166.77 M(-12.5%) |
Sep 2023 | - | $190.60 M(-0.3%) |
Jun 2023 | - | $191.16 M(+3.1%) |
Mar 2023 | - | $185.44 M(+9.8%) |
Dec 2022 | $633.65 M(+17.4%) | $168.89 M(+6.0%) |
Sep 2022 | - | $159.27 M(+1.7%) |
Jun 2022 | - | $156.55 M(+6.8%) |
Mar 2022 | - | $146.56 M(+12.5%) |
Dec 2021 | $539.59 M(+40.0%) | $130.33 M(+12.7%) |
Sep 2021 | - | $115.60 M(-19.2%) |
Jun 2021 | - | $143.00 M(-5.4%) |
Mar 2021 | - | $151.10 M(+31.8%) |
Dec 2020 | $385.52 M(+43.4%) | $114.67 M(+20.2%) |
Sep 2020 | - | $95.40 M(+2.7%) |
Jun 2020 | - | $92.93 M(+11.6%) |
Mar 2020 | - | $83.24 M(+11.6%) |
Dec 2019 | $268.78 M | $74.58 M(+19.2%) |
Sep 2019 | - | $62.55 M(+1.6%) |
Jun 2019 | - | $61.55 M(-12.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $70.08 M(+32.5%) |
Dec 2018 | $195.23 M(+52.5%) | $52.90 M(+18.8%) |
Sep 2018 | - | $44.54 M(-17.9%) |
Jun 2018 | - | $54.28 M(+25.5%) |
Mar 2018 | - | $43.25 M(+14.3%) |
Dec 2017 | $128.05 M(+49.2%) | $37.82 M(+0.8%) |
Sep 2017 | - | $37.51 M(+35.8%) |
Jun 2017 | - | $27.63 M(+8.4%) |
Mar 2017 | - | $25.50 M(+1.5%) |
Dec 2016 | $85.80 M(+54.8%) | $25.11 M(+17.5%) |
Sep 2016 | - | $21.37 M(+18.6%) |
Jun 2016 | - | $18.02 M(-14.7%) |
Mar 2016 | - | $21.13 M(+20.8%) |
Dec 2015 | $55.42 M(+60.5%) | $17.49 M(+66.8%) |
Sep 2015 | - | $10.48 M(-35.8%) |
Jun 2015 | - | $16.34 M(+48.7%) |
Mar 2015 | - | $10.99 M(-11.0%) |
Dec 2014 | $34.54 M(+71.9%) | $12.35 M(+69.8%) |
Sep 2014 | - | $7.27 M(-13.0%) |
Jun 2014 | - | $8.36 M(+35.4%) |
Mar 2014 | - | $6.17 M(+38.3%) |
Dec 2013 | $20.09 M(+11.1%) | $4.46 M |
Dec 2012 | $18.09 M | - |
FAQ
- What is Ascendis Pharma A/S annual total operating expenses?
- What is the all time high annual operating expenses for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual operating expenses year-on-year change?
- What is Ascendis Pharma A/S quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly operating expenses year-on-year change?
What is Ascendis Pharma A/S annual total operating expenses?
The current annual operating expenses of ASND is $647.40 M
What is the all time high annual operating expenses for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual total operating expenses is $733.86 M
What is Ascendis Pharma A/S annual operating expenses year-on-year change?
Over the past year, ASND annual total operating expenses has changed by -$86.46 M (-11.78%)
What is Ascendis Pharma A/S quarterly total operating expenses?
The current quarterly operating expenses of ASND is $170.03 M
What is the all time high quarterly operating expenses for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly total operating expenses is $191.16 M
What is Ascendis Pharma A/S quarterly operating expenses year-on-year change?
Over the past year, ASND quarterly total operating expenses has changed by +$129.40 K (+0.08%)